Expression and modulation of the intermediate-conductance Ca 2+-activated K+ channel in glioblastoma GL-15 cells

Bernard Fioretti, Emilia Castigli, Maria R. Micheli, Rodolfo Bova, Miriam Sciaccaluga, Alexander Harper, Fabio Franciolini, Luigi Catacuzzeno

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

We report here the expression and properties of the intermediate- conductance Ca2+-activated K+ (IKCa) channel in the GL-15 human glioblastoma cell line. Macroscopic IKCa currents on GL-15 cells displayed a mean amplitude of 7.2±0.8 pA/pF at 0 mV, at day 1 after plating. The current was inhibited by clotrimazole (CTL, IC 50=257 nM), TRAM-34 (IC50=55 nM), and charybdotoxin (CTX, IC50=10.3 nM). RT-PCR analysis demonstrated the expression of mRNA encoding the IKCa channel in GL-15 cells. Unitary currents recorded using the inside-out configuration had a conductance of 25 pS, a KD for Ca2+ of 188 nM at -100 mV, and no voltage dependence. We tested whether the IKCa channel expression in GL-15 cells could be the result of an increased ERK activity. Inhibition of the ERK pathway with the MEK antagonist PD98059 (25 μM, for 5 days) virtually suppressed the IK Ca current in GL-15 cells. PD98059 treatment also increased the length of cellular processes and up-regulated the astrocytic differentiative marker GFAP. A significant reduction of the IKCa current amplitude was also observed with time in culture, with mean currents of 7.17±0.75 pA/pF at 1-2 days, and 3.11±1.35 pA/pF at 5-6 days after plating. This time-dependent down-regulation of the IKCa current was not accompanied by changes in the ERK activity, as assessed by immunoblot analysis. Semiquantitative RT-PCR analysis demonstrated a ∼35% reduction of the IKCa channel mRNA resulting from ERK inhibition and a ∼50% reduction with time in culture.

Original languageEnglish
Pages (from-to)47-56
Number of pages10
JournalCellular Physiology and Biochemistry
Volume18
Issue number1-3
Publication statusPublished - 2006

Fingerprint

Glioblastoma
Inhibitory Concentration 50
Charybdotoxin
Clotrimazole
Calcium-Activated Potassium Channels
Polymerase Chain Reaction
Messenger RNA
MAP Kinase Signaling System
Down-Regulation
Cell Line
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one

Keywords

  • Cell differentiation
  • ERK
  • GFAP
  • Human glioblastoma GL-15 cell line
  • Intermediate-conductance Ca-activated K channels

ASJC Scopus subject areas

  • Physiology
  • Cell Biology

Cite this

Fioretti, B., Castigli, E., Micheli, M. R., Bova, R., Sciaccaluga, M., Harper, A., ... Catacuzzeno, L. (2006). Expression and modulation of the intermediate-conductance Ca 2+-activated K+ channel in glioblastoma GL-15 cells. Cellular Physiology and Biochemistry, 18(1-3), 47-56.

Expression and modulation of the intermediate-conductance Ca 2+-activated K+ channel in glioblastoma GL-15 cells. / Fioretti, Bernard; Castigli, Emilia; Micheli, Maria R.; Bova, Rodolfo; Sciaccaluga, Miriam; Harper, Alexander; Franciolini, Fabio; Catacuzzeno, Luigi.

In: Cellular Physiology and Biochemistry, Vol. 18, No. 1-3, 2006, p. 47-56.

Research output: Contribution to journalArticle

Fioretti, B, Castigli, E, Micheli, MR, Bova, R, Sciaccaluga, M, Harper, A, Franciolini, F & Catacuzzeno, L 2006, 'Expression and modulation of the intermediate-conductance Ca 2+-activated K+ channel in glioblastoma GL-15 cells', Cellular Physiology and Biochemistry, vol. 18, no. 1-3, pp. 47-56.
Fioretti, Bernard ; Castigli, Emilia ; Micheli, Maria R. ; Bova, Rodolfo ; Sciaccaluga, Miriam ; Harper, Alexander ; Franciolini, Fabio ; Catacuzzeno, Luigi. / Expression and modulation of the intermediate-conductance Ca 2+-activated K+ channel in glioblastoma GL-15 cells. In: Cellular Physiology and Biochemistry. 2006 ; Vol. 18, No. 1-3. pp. 47-56.
@article{e6d2298f9ca04d1b93b5d41a4dc49c27,
title = "Expression and modulation of the intermediate-conductance Ca 2+-activated K+ channel in glioblastoma GL-15 cells",
abstract = "We report here the expression and properties of the intermediate- conductance Ca2+-activated K+ (IKCa) channel in the GL-15 human glioblastoma cell line. Macroscopic IKCa currents on GL-15 cells displayed a mean amplitude of 7.2±0.8 pA/pF at 0 mV, at day 1 after plating. The current was inhibited by clotrimazole (CTL, IC 50=257 nM), TRAM-34 (IC50=55 nM), and charybdotoxin (CTX, IC50=10.3 nM). RT-PCR analysis demonstrated the expression of mRNA encoding the IKCa channel in GL-15 cells. Unitary currents recorded using the inside-out configuration had a conductance of 25 pS, a KD for Ca2+ of 188 nM at -100 mV, and no voltage dependence. We tested whether the IKCa channel expression in GL-15 cells could be the result of an increased ERK activity. Inhibition of the ERK pathway with the MEK antagonist PD98059 (25 μM, for 5 days) virtually suppressed the IK Ca current in GL-15 cells. PD98059 treatment also increased the length of cellular processes and up-regulated the astrocytic differentiative marker GFAP. A significant reduction of the IKCa current amplitude was also observed with time in culture, with mean currents of 7.17±0.75 pA/pF at 1-2 days, and 3.11±1.35 pA/pF at 5-6 days after plating. This time-dependent down-regulation of the IKCa current was not accompanied by changes in the ERK activity, as assessed by immunoblot analysis. Semiquantitative RT-PCR analysis demonstrated a ∼35{\%} reduction of the IKCa channel mRNA resulting from ERK inhibition and a ∼50{\%} reduction with time in culture.",
keywords = "Cell differentiation, ERK, GFAP, Human glioblastoma GL-15 cell line, Intermediate-conductance Ca-activated K channels",
author = "Bernard Fioretti and Emilia Castigli and Micheli, {Maria R.} and Rodolfo Bova and Miriam Sciaccaluga and Alexander Harper and Fabio Franciolini and Luigi Catacuzzeno",
year = "2006",
language = "English",
volume = "18",
pages = "47--56",
journal = "Cellular Physiology and Biochemistry",
issn = "1015-8987",
publisher = "S. Karger AG",
number = "1-3",

}

TY - JOUR

T1 - Expression and modulation of the intermediate-conductance Ca 2+-activated K+ channel in glioblastoma GL-15 cells

AU - Fioretti, Bernard

AU - Castigli, Emilia

AU - Micheli, Maria R.

AU - Bova, Rodolfo

AU - Sciaccaluga, Miriam

AU - Harper, Alexander

AU - Franciolini, Fabio

AU - Catacuzzeno, Luigi

PY - 2006

Y1 - 2006

N2 - We report here the expression and properties of the intermediate- conductance Ca2+-activated K+ (IKCa) channel in the GL-15 human glioblastoma cell line. Macroscopic IKCa currents on GL-15 cells displayed a mean amplitude of 7.2±0.8 pA/pF at 0 mV, at day 1 after plating. The current was inhibited by clotrimazole (CTL, IC 50=257 nM), TRAM-34 (IC50=55 nM), and charybdotoxin (CTX, IC50=10.3 nM). RT-PCR analysis demonstrated the expression of mRNA encoding the IKCa channel in GL-15 cells. Unitary currents recorded using the inside-out configuration had a conductance of 25 pS, a KD for Ca2+ of 188 nM at -100 mV, and no voltage dependence. We tested whether the IKCa channel expression in GL-15 cells could be the result of an increased ERK activity. Inhibition of the ERK pathway with the MEK antagonist PD98059 (25 μM, for 5 days) virtually suppressed the IK Ca current in GL-15 cells. PD98059 treatment also increased the length of cellular processes and up-regulated the astrocytic differentiative marker GFAP. A significant reduction of the IKCa current amplitude was also observed with time in culture, with mean currents of 7.17±0.75 pA/pF at 1-2 days, and 3.11±1.35 pA/pF at 5-6 days after plating. This time-dependent down-regulation of the IKCa current was not accompanied by changes in the ERK activity, as assessed by immunoblot analysis. Semiquantitative RT-PCR analysis demonstrated a ∼35% reduction of the IKCa channel mRNA resulting from ERK inhibition and a ∼50% reduction with time in culture.

AB - We report here the expression and properties of the intermediate- conductance Ca2+-activated K+ (IKCa) channel in the GL-15 human glioblastoma cell line. Macroscopic IKCa currents on GL-15 cells displayed a mean amplitude of 7.2±0.8 pA/pF at 0 mV, at day 1 after plating. The current was inhibited by clotrimazole (CTL, IC 50=257 nM), TRAM-34 (IC50=55 nM), and charybdotoxin (CTX, IC50=10.3 nM). RT-PCR analysis demonstrated the expression of mRNA encoding the IKCa channel in GL-15 cells. Unitary currents recorded using the inside-out configuration had a conductance of 25 pS, a KD for Ca2+ of 188 nM at -100 mV, and no voltage dependence. We tested whether the IKCa channel expression in GL-15 cells could be the result of an increased ERK activity. Inhibition of the ERK pathway with the MEK antagonist PD98059 (25 μM, for 5 days) virtually suppressed the IK Ca current in GL-15 cells. PD98059 treatment also increased the length of cellular processes and up-regulated the astrocytic differentiative marker GFAP. A significant reduction of the IKCa current amplitude was also observed with time in culture, with mean currents of 7.17±0.75 pA/pF at 1-2 days, and 3.11±1.35 pA/pF at 5-6 days after plating. This time-dependent down-regulation of the IKCa current was not accompanied by changes in the ERK activity, as assessed by immunoblot analysis. Semiquantitative RT-PCR analysis demonstrated a ∼35% reduction of the IKCa channel mRNA resulting from ERK inhibition and a ∼50% reduction with time in culture.

KW - Cell differentiation

KW - ERK

KW - GFAP

KW - Human glioblastoma GL-15 cell line

KW - Intermediate-conductance Ca-activated K channels

UR - http://www.scopus.com/inward/record.url?scp=33748990315&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748990315&partnerID=8YFLogxK

M3 - Article

VL - 18

SP - 47

EP - 56

JO - Cellular Physiology and Biochemistry

JF - Cellular Physiology and Biochemistry

SN - 1015-8987

IS - 1-3

ER -